ALSERES PHARMACEUTICALS, INC.

News Alseres Pharmaceuticals, Inc.

Equities

ALSE

US0211522026

Market Closed - OTC Markets Other stock markets 19:06:50 18/10/2023 BST			5-day change	1st Jan Change
0.005 ^USD	-50.00%		-.--%	-.--%

2015	Alseres Pharmaceuticals, Inc. cancelled the acquisition of E-IACFT Injection from Navidea Biopharmaceuticals, Inc.	CI
2015	Alseres Pharmaceuticals, Inc. will Change its Ticker to ALSE from ALSED	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Alseres Pharmaceuticals, Inc. cancelled the acquisition of E-IACFT Injection from Navidea Biopharmaceuticals, Inc.	21/04/15	CI
Alseres Pharmaceuticals, Inc. will Change its Ticker to ALSE from ALSED	29/01/15	CI
Alseres Pharmaceuticals, Inc. Auditor Raises 'Going Concern' Doubt	10/04/14	CI
Alseres Pharmaceuticals, Inc. Auditor Raises 'Going Concern' Doubt	01/04/13	CI
Alseres Pharmaceuticals, Inc. Licenses Altropane Rights to Navidea Biopharmaceuticals	06/08/12	CI
Alseres Pharmaceuticals, Inc. entered into an agreement to acquire E-IACFT Injection from Navidea Biopharmaceuticals, Inc for $3.4 million.	06/08/12	CI
Alseres Pharmaceuticals, Inc. Taken Out Licensing Agreement with Alseres Pharmaceuticals, Inc	02/08/12	CI
Alseres Pharmaceuticals, Inc. Reports License of Altropane(R) Worldwide Rights to Navidea Biopharmaceuticals, Inc	31/07/12	CI
Alseres Pharmaceuticals, Inc. announced that it has received $34.4 million in funding from Highbridge Capital Management, LLC, Ingalls & Snyder LLC, and other investors.	17/07/12	CI
Navidea Biopharmaceuticals to Continue its Diligence Through the End of July 2012 with Alseres Pharmaceuticals, Inc. to License E-IAFCT Injection	02/07/12	CI
Alseres Pharmaceuticals, Inc. Auditor Raises 'Going Concern' Doubt	29/03/12	CI
Navidea Biopharmaceuticals, Inc. Signs Option Agreement with Alseres Pharmaceuticals, Inc., to License Altropane	26/01/12	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Stock Market
Equities
ALSE Stock
News Alseres Pharmaceuticals, Inc.

As early as today, start finding the best investment opportunities!

Optimize my profits

fermer